Literature DB >> 8229508

Galactosemia: the uridine diphosphate galactose deficiency-uridine treatment controversy.

J B Holton1, F de la Cruz, H L Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8229508     DOI： 10.1016/s0022-3476(05)80404-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

1.  Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group.

Authors:  J H Walter; J E Collins; J V Leonard
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

Review 2.  Innovative therapy for Classic Galactosemia - tale of two HTS.

Authors:  M Tang; S I Odejinmi; H Vankayalapati; K J Wierenga; K Lai
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

Review 3.  Galactosaemia: pathogenesis and treatment.

Authors:  J B Holton
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  UDP-glucose and UDP-galactose concentrations in cultured skin fibroblasts of patients with classical galactosaemia.

Authors:  N J Keevill; J B Holton; J T Allen
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada).

Authors:  H A Risch; M Jain; L D Marrett; G R Howe
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

Review 6.  Defective galactosylation in galactosemia: is low cell UDPgalactose an explanation?

Authors:  S Segal
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 7.  Measurements of uridine diphosphate glucose and uridine diphosphate galactose--an appraisal.

Authors:  H N Kirkman
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.